AAGAB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.030400E-01
Normal-vs-Stage2
5.309200E-01
Normal-vs-Stage3
4.863200E-01
Normal-vs-Stage4
9.277800E-01
Stage1-vs-Stage2
3.302400E-01
Stage1-vs-Stage3
7.558100E-02
Stage1-vs-Stage4
1.512370E-01
Stage2-vs-Stage3
1.212960E-01
Stage2-vs-Stage4
4.302400E-01
Stage3-vs-Stage4
4.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.089000E-01
Normal-vs-AfricanAmerican
4.607400E-01
Normal-vs-Asian
7.029600E-01
Caucasian-vs-AfricanAmerican
9.324600E-01
Caucasian-vs-Asian
7.629400E-01
AfricanAmerican-vs-Asian
9.140800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.832200E-01
Normal-vs-Female
5.951000E-01
Male-vs-Female
4.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.216600E-01
Normal-vs-Age(41-60Yrs)
3.054200E-01
Normal-vs-Age(61-80Yrs)
7.073400E-01
Normal-vs-Age(81-100Yrs)
4.609000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.255400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.302400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.343400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.530400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.614000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.903200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.439800E-01
Normal-vs-Daily Drinker
7.824800E-01
Normal-vs-Weekly Drinker
8.126200E-01
Normal-vs-Occasional Drinker
4.267200E-01
Normal-vs-Social Drinker
5.385400E-01
Non Drinker-vs-Daily Drinker
7.007600E-01
Non Drinker-vs-Weekly Drinker
5.874600E-01
Non Drinker-vs-Occasional Drinker
4.493600E-01
Non Drinker-vs-Social Drinker
9.966400E-01
Daily Drinker-vs-Weekly Drinker
8.587600E-01
Daily Drinker-vs-Occasional Drinker
2.991200E-01
Daily Drinker-vs-Social Drinker
7.223800E-01
Weekly Drinker-vs-Occasional Drinker
2.414800E-01
Weekly Drinker-vs-Social Drinker
5.558600E-01
Occasional Drinker-vs-Social Drinker
4.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.785600E-01
Normal-vs-Grade 2
8.695400E-01
Normal-vs-Grade 3
8.252400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.968000E-01
Grade 1-vs-Grade 3
4.463600E-01
Grade 1-vs-Grade 4
8.785600E-01
Grade 2-vs-Grade 3
3.922600E-01
Grade 2-vs-Grade 4
8.695400E-01
Grade 3-vs-Grade 4
8.252400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.803600E-01
Normal-vs-NonDiabetic
4.801000E-01
Diabetic-vs-NonDiabetic
8.342400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.916830E-01
Normal-vs-NoPancreatitis
5.990600E-01
Pancreatitis-vs-NoPancreatitis
1.260100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.267400E-01
Normal-vs-N1
5.196200E-01
N0-vs-N1
9.305800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.123800E-02
Normal-vs-TP53-NonMutant
1.706380E-01
TP53-Mutant-vs-TP53-NonMutant
5.532300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
